Search Results for: Vegetable by-products in form of pellets
halo pharma september , east rutherford, nj – sept , – cambrex corporation (nyse: cbm), a leading manufacturer of small molecule innovator and generic active pharmaceutical ingredients (apis), today announced it has completed the acquisition of halo pharma (halo), a leading dosage form contract development
," commented steve klosk, president and ceo of cambrex. shawn cavanagh, coo of cambrex commented, "this acquisition expands our manufacturing footprint with the addition of two state-of-the art, gmp compliant manufacturing facilities in north america, both with a strong reputation for quality and excellent...
https://www.cambrex.com/cambrex-acquires-halo-pharma/